Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage

Alexander Everhart; Katrina Harper; Molly Moore Jeffery; Zachary Levin; Nancy E Morden; Ashwini Sankar; Pinar Karaca-Mandic

doi:10.1001/jamanetworkopen.2021.27349

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage

JAMA Netw Open. 2021 Sep 1;4(9):e2127349. doi: 10.1001/jamanetworkopen.2021.27349.

Authors

Alexander Everhart^{1

2}, Katrina Harper³, Molly Moore Jeffery⁴, Zachary Levin¹, Nancy E Morden^{5

6}, Ashwini Sankar⁷, Pinar Karaca-Mandic^{7

8}

Affiliations

¹ University of Minnesota School of Public Health, Minneapolis, Minnesota.
² OptumLabs Visiting Fellow, Eden Prairie, Minnesota.
³ Technomics Research LLC, Medina, Minnesota.
⁴ Mayo Clinic, Rochester, Minnesota.
⁵ UnitedHealthcare, Minnetonka, Minnesota.
⁶ Dartmouth College, Hanover, New Hampshire.
⁷ Carlson School of Management, University of Minnesota, Minneapolis.
⁸ National Bureau of Economic Research, Cambridge, Massachusetts.

Abstract

This cohort study of health claims data examines trends in testosterone prescriptions for older men in the US following 2014 changes to the US Food and Drug Administration’s stance on testosterone’s effects and safety risks.

Publication types

Comparative Study
Research Support, N.I.H., Extramural

MeSH terms

Aged
Drug Utilization / statistics & numerical data
Humans
Hypogonadism / drug therapy
Insurance, Health / statistics & numerical data*
Male
Medicare Part C / statistics & numerical data*
Middle Aged
Myocardial Infarction / chemically induced
Practice Guidelines as Topic*
Prescriptions / statistics & numerical data*
Stroke / chemically induced
Testosterone / therapeutic use*
United States
United States Food and Drug Administration

Substances

Testosterone